Enzon Pharmaceuticals, Inc. (ENZN)
OTOTC · Common · CUSIP 293904108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ENZN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
293904108
Market Cap
Micro Cap · $54 Million
Business: Enzon Pharmaceuticals, Inc. is a biotechnology company that had been dedicated to the research and development of innovative therapeutics for patients with high unmet medical needs. Enzon receives royalty revenues on seven marketed products that utilize its proprietary Customized PEGylation Linker Technology platform.

Company Contact

CEO
George W. Hebard III
PFO
Richard L. Feinstein
Headquarters
20 Kingsbridge Road, Piscataway, NJ 08854
Phone
732-980-4500
Investor Relations
732-980-4717 · investor@enzon.com
General Email
ghebard@enzon.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »